timothy sykes logo

Stock News

Nuvation Bio Stock: Time to Buy or Sell?

Jack KelloggAvatar
Written by Jack Kellogg Reviewed by Ellis Hobbs Fact-checked by Matt Monaco
Updated 9/8/2025, 5:04 pm ET 9/8/2025, 5:04 pm ET | 5 min 5 min read
Nuvation Bio Stock: Time to Buy or Sell? Thumbnail

Nuvation Bio Inc.’s stocks have been trading down by -7.95 percent amid market uncertainty and investor caution.

Candlestick Chart

Live Update At 17:03:55 EST: On Monday, September 08, 2025 Nuvation Bio Inc. stock [NYSE: NUVB] is trending down by -7.95%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Overview of Nuvation Bio’s Reports and Metrics

As millionaire penny stock trader and teacher Tim Sykes, says, “Consistency is key in trading; don’t let emotions dictate your trades.” In the world of trading, emotions often cloud judgment and lead to impulsive decisions, which can be detrimental. Emphasizing consistency helps traders make informed, strategic decisions based on analysis rather than whims. It’s important for traders to maintain discipline and stick to their trading plans to achieve their financial goals.

Nuvation Bio recently reported some intriguing financial metrics. The company’s recent earnings show impressive cash flow changes of $200.12M, largely due to strategic transactions in investments and debt management. However, the company’s profitability ratios tell a different tale. With an astonishingly high EBIT margin of -1,408.7 and a gross margin at 27.5, profitability seems far out of reach for now.

The current revenue stands at about $7.87M, but the Price-to-Sales ratio is quite steep at 92.99. This highlights the premium investors are placing on potential rather than on current output. On the balance sheet front, the company boasts a solid Current Ratio of 9.4, showing strong liquidity and operational security. In contrast, the relatively low return on equity (ROE) of -32.27 suggests that current equity holders might not be seeing impressive returns now.

While the results show a consistent development in key financial areas, profitability is still a concern. This could explain why the stock’s trajectory is volatile, affected significantly by market shifts and investor sentiment changes, as seen in recent daily price movements.

Understanding the Nuvation Bio Stock Surge

Recent developments and financial results have driven the latest stock movements. Despite ongoing operational losses, there appears to be a consistent optimistic view amongst traders, as seen in the continuing upward trend in the stock price. The $3.49 close price on Sep 5, 2025, demonstrates a noticeable leap from previous lows. The fact that Nuvation Bio continues to attract traders despite posting negative earnings and return ratios hints at robust future growth expectations possibly tied to its innovative glove.

Over the past month, as the trading volume increases, trader sentiment seems buoyed by the focus on future growth prospects and advancements in particular sectors where Nuvation Bio has announced developments. Market participants appear generally optimistic about potential returns, notwithstanding current financial hurdles. As millionaire penny stock trader and teacher Tim Sykes says, “The goal is not to win every trade but to protect your capital and keep moving forward.”

This volatile price action aligns with high-risk appetite and the speculative nature that comes with markets that have yet to see significant profitability. With highs and lows shifting rapidly, quick on-the-spot decisions become common. Being a biotech stock, affected by speculative news and the innovative potential tied to biotech advancements, shifts in market dynamics also play a role.

In summary, though Nuvation Bio’s financials show continued developmental progress, the high level of trading capital against income reflects a strong focus on future potential rather than present-day earnings. Traders should weigh these aspects carefully when deciding to buy or sell at the current juncture. The stock’s movements are currently more reflective of market sentiment driving its momentum rather than traditional financial indicators. As such, potential traders should stay sharp and informed, considering the gradual build-up and innovations underway within the company.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply
Author card Timothy Sykes picture

Jack Kellogg

He teaches webinars on Tim Sykes’ Trading Challenge He became Tim’s youngest millionaire student in 2020. Now he’s second on the Trading Challenge leaderboard with $12.9 million in career earnings. He’s a master of the 7-Step Pennystocking Framework. Jack is one of a rare breed of traders to profitably trade the entire penny stock framework.
Read More

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”